37:
369:
30:
539:
399:
417:
384:
216:
374:
460:
51:
544:
434:
422:
379:
122:
258:
146:
273:
278:
191:
107:
237:
15:
348:
464:
161:
428:
533:
474:
283:
201:
117:
64:
328:
268:
186:
176:
166:
156:
55:
47:
333:
308:
303:
298:
263:
206:
196:
131:
92:
353:
323:
318:
313:
242:
232:
227:
181:
171:
102:
97:
87:
82:
77:
343:
338:
293:
288:
136:
502:
will show the template collapsed, i.e. hidden apart from its title bar.
467:), it is hidden apart from its title bar; if not, it is fully visible.
459:, meaning that if there is another collapsible item on the page (a
19:
526:
will show the template expanded, i.e. fully visible.
505:
481:
362:
251:
215:
145:
116:
63:
470:To change this template's initial visibility, the
370:Bismuth subcitrate/metronidazole/tetracycline
31:
8:
38:
24:
16:
454:initial visibility currently defaults to
471:
385:Vonoprazan/amoxicillin/clarithromycin
7:
465:table with the collapsible attribute
14:
540:Drugs for acid-related disorders
375:Omeprazole/amoxicillin/rifabutin
510:Drugs for peptic ulcer and GORD
486:Drugs for peptic ulcer and GORD
1:
561:
412:
393:
93:Lavoltidine (loxtidine)
380:Vonoprazan/amoxicillin
217:Potassium-competitive
147:Proton-pump inhibitors
545:Drug templates by ATC
403:eradication protocols
259:Aceglutamide aluminum
274:Arbaclofen placarbil
401:Helicobacter pylori
439:Never to phase III
279:Bismuth subcitrate
449:
448:
552:
525:
524:
520:
517:
514:
511:
508:
501:
500:
496:
493:
490:
487:
484:
473:
472:|state=
457:
452:This template's
349:Zinc L-carnosine
40:
33:
26:
17:
560:
559:
555:
554:
553:
551:
550:
549:
530:
529:
522:
518:
515:
512:
509:
506:
498:
494:
491:
488:
485:
482:
461:navbox, sidebar
455:
450:
445:
444:
429:Clinical trials
408:
389:
358:
247:
218:
211:
162:Dexlansoprazole
149:
141:
121:
112:
68:
59:
44:
12:
11:
5:
558:
556:
548:
547:
542:
532:
531:
528:
527:
503:
447:
446:
443:
442:
441:
440:
437:
426:
420:
414:
413:
410:
409:
407:
406:
394:
391:
390:
388:
387:
382:
377:
372:
366:
364:
360:
359:
357:
356:
351:
346:
341:
336:
331:
326:
321:
316:
311:
306:
301:
296:
291:
286:
281:
276:
271:
266:
261:
255:
253:
249:
248:
246:
245:
240:
235:
230:
224:
222:
213:
212:
210:
209:
204:
199:
194:
189:
184:
179:
174:
169:
164:
159:
153:
151:
143:
142:
140:
139:
134:
128:
126:
118:Prostaglandins
114:
113:
111:
110:
105:
100:
95:
90:
85:
80:
74:
72:
66:
61:
60:
45:
43:
42:
35:
28:
20:
13:
10:
9:
6:
4:
3:
2:
557:
546:
543:
541:
538:
537:
535:
504:
480:
479:
478:
477:may be used:
476:
468:
466:
462:
458:
438:
436:
433:
432:
430:
427:
424:
421:
419:
416:
415:
411:
405:
404:
402:
396:
395:
392:
386:
383:
381:
378:
376:
373:
371:
368:
367:
365:
361:
355:
352:
350:
347:
345:
342:
340:
337:
335:
332:
330:
327:
325:
322:
320:
317:
315:
312:
310:
307:
305:
302:
300:
297:
295:
292:
290:
287:
285:
284:Carbenoxolone
282:
280:
277:
275:
272:
270:
267:
265:
262:
260:
257:
256:
254:
250:
244:
241:
239:
236:
234:
231:
229:
226:
225:
223:
220:
219:acid blockers
214:
208:
205:
203:
202:Tenatoprazole
200:
198:
195:
193:
190:
188:
185:
183:
180:
178:
175:
173:
170:
168:
165:
163:
160:
158:
155:
154:
152:
148:
144:
138:
135:
133:
130:
129:
127:
124:
119:
115:
109:
106:
104:
101:
99:
96:
94:
91:
89:
86:
84:
81:
79:
76:
75:
73:
70:
62:
57:
53:
49:
41:
36:
34:
29:
27:
22:
21:
18:
469:
456:autocollapse
453:
451:
400:
397:
363:Combinations
329:Sulglicotide
269:Alginic acid
187:Pantoprazole
177:Lansoprazole
167:Esomeprazole
157:Azeloprazole
150:("-prazole")
48:peptic ulcer
23:
425:from market
334:Telenzepine
309:Pirenzepine
304:Lesogaberan
299:Irsogladine
264:Acetoxolone
221:("-prazan")
207:Timoprazole
197:Rabeprazole
192:Picoprazole
132:Misoprostol
125:("-prost-")
71:("-tidine")
69:antagonists
534:Categories
398:See also:
354:Zolimidine
324:Sucralfate
319:Rebamipide
314:Proglumide
243:Vonoprazan
238:Soraprazan
233:Revaprazan
228:Linaprazan
182:Omeprazole
172:Ilaprazole
108:Roxatidine
103:Ranitidine
98:Nizatidine
88:Lafutidine
83:Famotidine
78:Cimetidine
46:Drugs for
497:collapsed
475:parameter
435:Phase III
423:Withdrawn
344:Troxipide
339:Teprenone
294:Gefarnate
289:Cetraxate
137:Enprostil
123:analogues
52:GERD/GORD
521:expanded
418:WHO-EM
252:Others
516:state
492:state
463:, or
120:(E)/
56:A02B
50:and
536::
523:}}
507:{{
499:}}
483:{{
431::
519:=
513:|
495:=
489:|
67:2
65:H
58:)
54:(
39:e
32:t
25:v
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.